ImmunoPrecise Antibodies is a biotech and techbio company with roots in British Columbia that supports therapeutic antibody discovery and development. The business combines antibody discovery services with artificial intelligence and multi-omics analysis, and highlights proprietary platforms such as LENSai, HYFT and B Cell Select to support complex biologics programs.
Antibody discovery, biologics, AI-enabled drug discovery, multi-omics modeling, epitope mapping, therapeutic antibody development, bioinformatics, and integrated wet-lab and computational research.
Therapeutic antibody discovery services, AI-driven target and epitope analysis, B Cell Select antibody discovery workflows, HYFT and LENSai platform capabilities, and biologics development support.